Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Type 1 CMT Gene Therapy Project Now Underway
…Accelerate Research (STAR) brings top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs. STAR has one goal: to accelerate the development of treatments for CMT. Both research…
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
…their work. The CMTA has invested $23.5 million in its Strategy to Accelerate Research (STAR) since it was implemented in 2008, making it the world’s largest funder of CMT research….
Development of Treatments for CMT2D
…support the CMTA’s research efforts and enable expanded partnerships with world leading research laboratories, please consider making a donation in support of the CMTA’s Strategy to Accelerate Research. Published: June…
CMTA Appoints David Skarinsky to its Therapy Expert Board
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research that’s aimed at bringing treatments and a cure to patients of this rare disease, is pleased to…
Type 1 CMT Gene Therapy Project Now Underway
…Accelerate Research (STAR) brings top researchers together with pharmaceutical and biotechnology partners to accelerate scientific breakthroughs. STAR has one goal: to accelerate the development of treatments for CMT. Both research…
CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A
…philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers, clinicians, and experts in therapy development together with pharmaceutical and biotechnology companies…
CMT Type 2
…metabolic engines of the cells. Research on CMT Type 2A Type 2A2B CMT2A2B is the recessive form of CMT2A. Historically, KIF1B was originally published as causing CMT2A. That turned out…
STAR Advisory Board
…soundness of the research strategy. The progress of research teams, recommending changes in research strategies as needed. The Therapy Expert Board (TEB) evaluates the translational quality of ongoing and proposed…
CMTAfall2022web
…Katherine Forsey, PhD, to the newly created post of chief research officer on June 2. The move came in response to the explosive growth of the CMTA’s signature research program,…
CMTAfall2022web
…Katherine Forsey, PhD, to the newly created post of chief research officer on June 2. The move came in response to the explosive growth of the CMTA’s signature research program,…